Earnings Call · Q2 FY2021·2021-08-07

Q2 21EPS -29.76%·Rev n/aQ1 21EPS -30.12%·Rev n/aQ4 20EPS -9.33%·Rev n/aQ3 20EPS +100.00%*·Rev n/a⚠ consensus missing

Arcus Biosciences, Inc. RCUS

Katherine Bock — Investor Relations

Terry Rosen — Chief Executive Officer

Robert Goeltz — Chief Financial Officer

−10.6%1d on move date−10.7% vs SPY3d−6.0%5d−8.9%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more RCUS calls or request research access.

More RCUS calls Browse calls Request research access